S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
OTCMKTS:AMAR

Amarillo Biosciences Stock Forecast, Price & News

$0.45
-0.23 (-33.82%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.41
$0.69
50-Day Range
$0.39
$0.75
52-Week Range
$0.05
$1.97
Volume
7,152 shs
Average Volume
18,253 shs
Market Capitalization
$18.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.06
30 days | 90 days | 365 days | Advanced Chart
Receive AMAR News and Ratings via Email

Sign-up to receive the latest news and ratings for Amarillo Biosciences and its competitors with MarketBeat's FREE daily newsletter.


Amarillo Biosciences logo

About Amarillo Biosciences

Amarillo Biosciences, Inc., a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases. The Medical division focuses on medical devices and developing technology to treat metabolism related diseases, such as Type 1 and Type 2 diabetes. The Consumer division provides a range of nutraceutical and food supplement products that utilize a liposomal delivery system. It owns four issued patents related to the low-dose oral delivery of interferon; one patent is for a product promoting oral health; and three patents are associated with treatment of metabolic disorders. The company was incorporated in 1984 and is based in Amarillo, Texas.

Headlines

Amarillo Biosciences (OTCMKTS:AMAR) Stock Price Down 38.5%
November 26, 2021 |  americanbankingnews.com
US stocks lower midday on economic growth concerns
September 10, 2021 |  proactiveinvestors.com
AINOS Inc.
July 18, 2021 |  barrons.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:AMAR
Fax
N/A
Employees
2
Year Founded
N/A

Sales & Book Value

Annual Sales
$20 thousand
Book Value
($0.03) per share

Profitability

Net Income
$-1.45 million
Net Margins
-41,453.98%
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$18.93 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/14/2018
Today
12/02/2021

MarketRank

Overall MarketRank

1.24 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Amarillo Biosciences (OTCMKTS:AMAR) Frequently Asked Questions

How has Amarillo Biosciences' stock been impacted by Coronavirus (COVID-19)?

Amarillo Biosciences' stock was trading at $0.27 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AMAR stock has increased by 66.7% and is now trading at $0.45.
View which stocks have been most impacted by COVID-19
.

How were Amarillo Biosciences' earnings last quarter?

Amarillo Biosciences, Inc. (OTCMKTS:AMAR) released its quarterly earnings results on Wednesday, November, 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.02 million for the quarter.
View Amarillo Biosciences' earnings history
.

Who are Amarillo Biosciences' key executives?

Amarillo Biosciences' management team includes the following people:
  • Dr. Stephen T. Chen, Chairman, CEO, Pres, CFO & COO (Age 71, Pay $340.98k)
  • Mr. Bernard Cohen, VP of Admin. (Age 68, Pay $83.08k)
  • Mr. John Junyong Lee Esq., Chief Legal Counsel & Sec.

What other stocks do shareholders of Amarillo Biosciences own?

What is Amarillo Biosciences' stock symbol?

Amarillo Biosciences trades on the OTCMKTS under the ticker symbol "AMAR."

How do I buy shares of Amarillo Biosciences?

Shares of AMAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Amarillo Biosciences' stock price today?

One share of AMAR stock can currently be purchased for approximately $0.45.

How much money does Amarillo Biosciences make?

Amarillo Biosciences has a market capitalization of $18.93 million and generates $20 thousand in revenue each year.

How many employees does Amarillo Biosciences have?

Amarillo Biosciences employs 2 workers across the globe.

What is Amarillo Biosciences' official website?

The official website for Amarillo Biosciences is www.amarbio.com.

Where are Amarillo Biosciences' headquarters?

Amarillo Biosciences is headquartered at 4134 BUSINESS PARK DRIVE, AMARILLO TX, 79110.

How can I contact Amarillo Biosciences?

Amarillo Biosciences' mailing address is 4134 BUSINESS PARK DRIVE, AMARILLO TX, 79110. The company can be reached via phone at 806-376-1741 or via email at [email protected].


This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.